news bytes
blood for self-use.”
Avantor acquires
cGMP buffers firm,
Puritan Products
Avantor Performance
Materials, LLC,
has announced the
acquisition of Puritan
Products, Inc., a supplier
of cGMP buffers and
solutions for Biopharma
customers, and high-
purity chemistries for
Research and Electronic
Materials customers.
“The addition of Puritan
is a key next step in
our growth plans, as it
provides access to new
customers in the U.S.
and Europe, a broader
portfolio of high-
purity products for the
Biopharma, Research
and Electronic Materials
industries, and access to
additional capabilities,
including new cGMP
operations and talented
68
BioVoiceNews | May 2017
new colleagues,” said
Michael Stubblefield, CEO
of Avantor. “The addition
of Puritan’s operations,
equipment and sourcing
of raw materials offer
our customers an
additional layer of supply
chain security, a key
element of the Avantor
value proposition.”
Bharat Biotech’s Zika
vaccine animal trials
show 100% efficacy
The Hyderabad-based
Bharat Biotech that
had earlier announced
its ambitious plans to
produce the zika vaccine
in India, has declared the
results of the studies on
the company’s Zika virus
vaccine. The inactivated
vaccine has shown 100
percent efficacy against
mortality and disease in
animal study. The vaccine
is based on the killed virus
vaccine contains virus
that has been grown in
culture and then killed
certain processes.
Published in the
Nature group journal
Scientific Reports, the
study mentions that
the two doses (5 and
10 microgram) of the
vaccine given through
intramuscular route on
days 0 and 21 to mice
were found to protect
the animals against Zika
virus seven days after
the second vaccination.
The vaccine was found
to confer 100 percent
protection against
infection caused by an
Asian Zika virus strain
as well as by the African
Zika virus strain. All the
animals that were not
vaccinated died eight
days after infection by
the African strain and
12 days after infection
by the Asian strain.
While all the animals
that received the vaccine
exhibited “undetectable”
viral load, the amount of
virus present in animals
that did not receive the
vaccine peaked four days
after being infected with
either the African or
Asian Zika virus strain.